<DOC>
	<DOCNO>NCT00829907</DOCNO>
	<brief_summary>The purpose study evaluate effect ORM-12741 receptor occupancy positron emission tomography different dos plasma concentration . The pharmacokinetic profile safety also evaluate .</brief_summary>
	<brief_title>A PET Study With ORM-12741</brief_title>
	<detailed_description />
	<criteria>Good general health ascertain detailed medical history physical examination Males 18 45 year Body mass index ( BMI ; weight/height2 ) 1830 kg/m2 Weight 5595 kg Evidence clinically significant cardiovascular , renal , hepatic , haematological , gastrointestinal , pulmonary , metabolicendocrine , neurological , urogenital psychiatric disease judge investigator Any condition require regular concomitant medication include herbal product likely need concomitant medication study Regular consumption 21 unit alcohol per week ( 1 unit = 4 cl spirit , 13 g alcohol ) . Current use nicotinecontaining product 5 cigarette equivalent/day Inability refrain use nicotinecontaining product stay study centre Inability refrain consume caffeinecontaining beverage stay study centre e.g . propensity headache refrain caffeinecontaining beverage Blood donation loss significant amount blood within 3 month prior screen visit Abnormal 12lead electrocardiogram ( ECG ) find clinical relevance Any abnormal value laboratory , vital sign , physical examination , may opinion investigator interfere interpretation test result cause health risk subject take part study Anatomical abnormality brain MRI may opinion investigator interfere interpretation PET result Participation another clinical drug study within 3 month prior start study earlier participation clinical study ORM12741 Participation prior PET study Any contraindication MRI brain</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Healthy volunteer study</keyword>
</DOC>